Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease

2010 ◽  
Vol 85 (6) ◽  
pp. 529-537 ◽  
Author(s):  
Iryna Rusanova ◽  
Germaine Escames ◽  
Gladys Cossio ◽  
Rosaura G. De Borace ◽  
Belgica Moreno ◽  
...  
2011 ◽  
Vol 412 (13-14) ◽  
pp. 1257-1261 ◽  
Author(s):  
Philippe Joly ◽  
Philippe Lacan ◽  
Caroline Garcia ◽  
Angelique Delasaux ◽  
Alain Francina

2010 ◽  
Vol 123 (3) ◽  
pp. 182-185 ◽  
Author(s):  
Abdul-Wahab M. Al-Saqladi ◽  
Bernard J. Brabin ◽  
Hassan A. Bin-Gadeem ◽  
Warsha A. Kanhai ◽  
Marion Phylipsen ◽  
...  

2003 ◽  
Vol 70 (2) ◽  
pp. 79-83 ◽  
Author(s):  
A. Inati ◽  
A. Taher ◽  
W. Bou Alawi W ◽  
S. Koussa ◽  
H. Kaspar ◽  
...  

2008 ◽  
Vol 20 (3) ◽  
pp. 342-344 ◽  
Author(s):  
Altheia Jones-Lecointe ◽  
Erskine Smith ◽  
Marc Romana ◽  
Marie-Georges Gilbert ◽  
Waveney P. Charles ◽  
...  

Antioxidants ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 296
Author(s):  
Rosa Vona ◽  
Nadia Maria Sposi ◽  
Lorenza Mattia ◽  
Lucrezia Gambardella ◽  
Elisabetta Straface ◽  
...  

Sickle cell disease (SCD) is the most common hereditary disorder of hemoglobin (Hb), which affects approximately a million people worldwide. It is characterized by a single nucleotide substitution in the β-globin gene, leading to the production of abnormal sickle hemoglobin (HbS) with multi-system consequences. HbS polymerization is the primary event in SCD. Repeated polymerization and depolymerization of Hb causes oxidative stress that plays a key role in the pathophysiology of hemolysis, vessel occlusion and the following organ damage in sickle cell patients. For this reason, reactive oxidizing species and the (end)-products of their oxidative reactions have been proposed as markers of both tissue pro-oxidant status and disease severity. Although more studies are needed to clarify their role, antioxidant agents have been shown to be effective in reducing pathological consequences of the disease by preventing oxidative damage in SCD, i.e., by decreasing the oxidant formation or repairing the induced damage. An improved understanding of oxidative stress will lead to targeted antioxidant therapies that should prevent or delay the development of organ complications in this patient population.


Sign in / Sign up

Export Citation Format

Share Document